Literature DB >> 20511571

Automated weight monitoring in chronic heart failure: the excluded majority.

Glenis Johnston1, Gwyn Weatherburn.   

Abstract

We interviewed nurses and patients with heart failure who were participating in a research trial of home telemonitoring in which weight data were monitored automatically by a call centre. A total of 35 interviews were conducted and the transcripts were analysed thematically. The results indicated that nurses disagreed about the role of weight monitoring and the practicalities of telemonitoring in their daily practice, indicating that the process was idiosyncratic to each user. The lack of personal feedback and nursing contact discouraged patients from weight monitoring, suggesting that a feedback mechanism may have to be adapted to suit patients. There were other factors which created barriers to acceptance by patients and staff. Home telemonitoring for heart failure cannot be evaluated effectively using the standard approach commonly employed. New studies are required.

Entities:  

Mesh:

Year:  2010        PMID: 20511571     DOI: 10.1258/jtt.2010.004007

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

1.  Contributors to frequent telehealth alerts including false alerts for patients with heart failure: a mixed methods exploration.

Authors:  K Radhakrishna; K Bowles; A Zettek-Sumner
Journal:  Appl Clin Inform       Date:  2013-10-09       Impact factor: 2.342

Review 2.  Home telehealth uptake and continued use among heart failure and chronic obstructive pulmonary disease patients: a systematic review.

Authors:  Sarah L Gorst; Christopher J Armitage; Simon Brownsell; Mark S Hawley
Journal:  Ann Behav Med       Date:  2014-12

Review 3.  Factors Affecting Patient and Physician Engagement in Remote Health Care for Heart Failure: Systematic Review.

Authors:  Ahmed Al-Naher; Jennifer Downing; Kathryn A Scott; Munir Pirmohamed
Journal:  JMIR Cardio       Date:  2022-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.